Edition:
United Kingdom

Adocia Announces Expanded Biochaperone Product Portfolio Beyond Diabetes


Thursday, 4 Jan 2018 

Jan 4 (Reuters) - ADOCIA SA ::ADOCIA ANNOUNCES EXPANDED BIOCHAPERONE® PRODUCT PORTFOLIO BEYOND DIABETES.BIOCHAPERONE TO BE DEPLOYED IN SELECTED RANGE OF INJECTABLE THERAPEUTICS ACROSS NUMEROUS THERAPEUTIC AREAS​.‍INITIAL PROGRAMS ADDED INCLUDE READY-TO-INJECT VERSION OF TEDUGLUTIDE FOR TREATMENT OF SHORT BOWEL SYNDROME​.‍INITIAL PROGRAMS ADDED INCLUDE FIXED DOSE COMBINATION OF GLUCAGON AND EXENATIDE FOR TREATMENT OF OBESITY​.‍EXPANSION OF PORTFOLIO CREATES NEW PARTNERSHIP OPPORTUNITIES​. 

Related Company News

Company Quote

11.32
-0.18 -1.57%
2:13pm BST